SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001491877-10-000002
Filing Date
2010-05-19
Accepted
2010-05-19 14:44:34
Documents
1
Period of Report
2010-05-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 22848
  Complete submission text file 0001491877-10-000002.txt   24881
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NABI BIOPHARMACEUTICALS 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address
Kessler Paul D. (Reporting) CIK: 0001428524 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 10844972